USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Redefining the Future of Biologics through Target-specific Drugs and Novel Technologies
25-Jul-2016
Europe
Market Research
NE20-01-00-00-00
CM01238-EU-MR_18863
This study provides an insight into the global biologics active pharmaceutical ingredients (API) market. According to the US FDA, “Biological products, or biologics, are medical products made from a variety of natural sources (human, animal, or microorganism). Biologics are intended to treat diseases & medical conditions and prevent or diagnose diseases.” Biologic drugs are significantly derived from monoclonal antibodies, recombinant proteins, vaccines, and others (e.g., cell therapy, gene therapy, antibody drug conjugates). In this study, drivers, restraints, and the competitive landscape as well as outsourcing and market and technology trends are discussed. Estimates and forecasts for the global market are provided from 2016 to 2020.
Key Findings
- Segment Growth Trends
- Technology Trend and Market Activities
- In-house vs. Outsourcing
CEO’s Perspective
Market Definitions
An Overview
Global Biologics API Product Segmentation and Therapeutic Categories
- Monoclonal antibodies
- Recombinant proteins
- Biologic vaccines
Antibody and Recombinant Protein Production Process
Vaccines and Gene Therapy Production Process
Market Drivers
Market Restraints
Regulatory Landscape—Biologics
Market Engineering Measurements
Revenue Forecast
Percent Revenue Breakdown by Region
Percent Revenue Breakdown by Biologic Drug Class
Global Trends in Biologics Market
Global Technology Trends in Biologics
Global Significant Expansions by Top Biopharma Companies and CMOs
Global Major Acquisitions by Top Biopharma Companies and CMOs
Top Biopharmaceutical Companies and Their Future Plans by 2020
Biologic Drug Pipeline across Therapeutic Categories and Biologic Class by Major Companies
Biologic Drugs Pipeline of Key Companies
Biologics API Market—Product Matrix
Porter’s Five Forces Analysis
Global Contract Manufacturing Partnerships
Best Practices in the Biopharma Industry
The Last Word
Legal Disclaimer
Major Companies
List of Figures
- 1. Total Biologics API Market: Key Market Drivers, Global, 2016–2020
- 2. Total Biologics API Market: Key Market Restraints, Global, 2016–2020
- 3. Total Biologics API Market: Market Engineering Measurements, Global, 2015
List of Charts
- 1. Total Biologics API Market: Revenue Forecast, Global, 2012–2020
- 2. Total Biologics API Market: Percent Revenue by Region, Global, 2015
- 3. Total Biologics API Market: Percent Revenue Breakdown by Biologic Drug Class, Global, 2015
- 4. Total Biologics API Market: Porter’s Five Forces Analysis, Global, 2015
Speak directly with our analytics experts for tailored recommendations.
Recent related Specialty Chemicals research
04 Sep 2026 | Global | Technology Research
Innovations in Nanotechnology Including Nanocellulose, 2D Nanomaterials, Nanomembranes, Nanotubes, and Alloy Nanoparticles for Diverse Industrial Applications
This issue of the Nanotechnology Opportunity Engine profiles significant advances in nanotechnology for various industrial applications. The featured innovations include Graphene-Enhanced Ballistic Composite for Defense Applications, Upcycling Carbon Waste into High-Quality, Sustainable Graphene, Gr...
24 Aug 2026 | South Asia, Middle East & North Africa | Market Research
Growth Opportunities in the Indian Intermediate Chemicals Industry, 2025–2030
The analysis covers a portfolio of import-dependent chemical intermediates and downstream derivatives in India. The growth opportunities are categorized into three strategic buckets namely, scalable opportunities, conditional bets, and plausible MOAT. Each consists of chemical intermediates filtered...
17 Aug 2026 | South Asia, Middle East & North Africa | Market Research
Growth Opportunities for Chlorine Derivatives, Middle East and North Africa, 2025–2030
This study assesses chlorine derivative opportunities across the MENA region. It analyzes the existing chlorine derivative landscape and identifies attractive specialty chlorine derivative opportunities.A comprehensive chlorine derivative universe was established based on global chlorine consumption...
14 Aug 2026 | Global | Technology Research
Innovations in Surface Technologies for Optical Coatings, Antifouling Coatings, Protective Coatings, Sustainable Packaging Coatings, and Others
This edition of the Advanced Coating & Surface Technology Opportunity Engine profiles significant advances in advanced coatings and surface treatments for various industrial applications. The featured innovations include Next-Generation Low-Emissivity Coatings for Lightweight Transparent Glazing, Pl...
07 Aug 2026 | Global | Technology Research
Innovations in Advanced Polymeric Materials, Circular Feedstocks, Graphene, Carbon Valorization, and Sustainable Functional Materials
This issue of High-Tech Materials Technology Opportunity Engine (TOE) profiles significant advances in high-tech materials for various industrial applications. The featured innovations include Advanced Hyperdispersant for Coating and Pigment Systems, Advanced Optical Brighteners for Multi-Industry A...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Table of Contents | | Executive Summary~ || Key Findings~ ||| Segment Growth Trends~ ||| Technology Trend and Market Activities~ ||| In-house vs. Outsourcing~ || CEO’s Perspective~ | Total Biologics API Market—An Overview~ || Market Definitions~ || An Overview~ ||| Monoclonal antibodies~ ||| Recombinant proteins~ ||| Biologic vaccines~ || Global Biologics API Product Segmentation and Therapeutic Categories~ || Antibody and Recombinant Protein Production Process~ || Vaccines and Gene Therapy Production Process~ | Market Drivers and Restraints~ || Market Drivers~ ||| Patent expiry of biologic drugs in the next 5 years~ ||| Rising disease population in therapeutic categories like oncology, cardiology, auto-immune, and diabetes~ ||| High priced biologic drugs along with growth in biosimilars~ || Market Restraints~ ||| Complexity in biologic API manufacturing~ ||| Regulatory scrutiny concerning quality policies and user fees for drug manufacturing~ || Regulatory Landscape—Biologics~ | Forecast and Trends~ || Market Engineering Measurements~ || Revenue Forecast~ || Percent Revenue Breakdown by Region~ || Percent Revenue Breakdown by Biologic Drug Class~ | Technology and Market Trends~ || Global Trends in Biologics Market~ ||| In-house vs. Outsourcing~ ||| Biosimilars Growth~ ||| Hybrid Methodology~ ||| Nanobodies~ || Global Technology Trends in Biologics~ ||| Single-use Systems~ ||| Replacement Technologies~ ||| Process Analytical Technology~ ||| Continuous Manufacturing~ ||| Green Chemistry~ || Global Significant Expansions by Top Biopharma Companies and CMOs~ || Global Major Acquisitions by Top Biopharma Companies and CMOs~ | Competitive Analysis~ || Top Biopharmaceutical Companies and Their Future Plans by 2020~ ||| Roche~ ||| Amgen~ ||| Sanofi~ ||| Novo Nordisk~ ||| Abbvie~ ||| J&J~ || Biologic Drug Pipeline across Therapeutic Categories and Biologic Class by Major Companies~ || Biologic Drugs Pipeline of Key Companies~ || Biologics API Market—Product Matrix~ || Porter’s Five Forces Analysis~ | In-house vs. Outsourcing~ || Global Contract Manufacturing Partnerships~ || Best Practices in the Biopharma Industry~ || The Last Word~ ||| Growth segments~ ||| Technologies for the future~ ||| Outsourcing strategy~ || Legal Disclaimer~ | Appendix~ || Major Companies~ | The Frost & Sullivan Story~ |
| List of Charts and Figures | 1. Total Biologics API Market: Key Market Drivers, Global, 2016–2020~ 2. Total Biologics API Market: Key Market Restraints, Global, 2016–2020~ 3. Total Biologics API Market: Market Engineering Measurements, Global, 2015~| 1. Total Biologics API Market: Revenue Forecast, Global, 2012–2020~ 2. Total Biologics API Market: Percent Revenue by Region, Global, 2015~ 3. Total Biologics API Market: Percent Revenue Breakdown by Biologic Drug Class, Global, 2015~ 4. Total Biologics API Market: Porter’s Five Forces Analysis, Global, 2015~ |
| Author | Arun Ramesh |
| Industries | Chemicals and Materials |
| WIP Number | NE20-01-00-00-00 |
| Is Prebook | No |
Analysis of the Global Biologics API Market
$3,000.00
Special Price $2,250.00 save 25 %